Kiniksa Pharmaceuticals International, plc
KNSA
43 insider filings · Latest: Sep 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Sep 3 8:40 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Sale | 4,600 | $80.30 | $369.4K | 29,062(D) | View → |
| Sep 3, 2026 | Sep 3 8:02 PM | Megna Michael R | Proposed Sale | 4,600 | $80.30 | $369.4K | — | View → |
| Jul 29, 2026 | Jul 31 8:34 PM | Bradley G ColeDirector | Sale | 3,673 | $81.43 | $299.1K | 11,672(D) | View → |
| Jul 29, 2026 | Jul 29 8:03 PM | Tessari Eben | Proposed Sale | 67,062 | $79.74 | $5.3M | — | View → |
| Jul 29, 2026 | Jul 29 8:02 PM | Cole G Bradley | Proposed Sale | 3,673 | $81.43 | $299.1K | — | View → |
| May 1, 2026 | May 5 8:54 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Sale | 58,424 | $53.71 | $3.1M | 65,623(D) | View → |
| May 1, 2026 | May 1 8:45 PM | Paolini John F. | Proposed Sale | 58,424 | $53.71 | $3.1M | — | View → |
| May 1, 2026 | May 1 8:32 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Sale | 48,565 | $54.02 | $2.6M | 0(D) | View → |
| Apr 30, 2026 | Apr 30 10:33 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Sale | 2,141 | $54.01 | $115.6K | 0(D) | View → |
| Apr 29, 2026 | Apr 30 10:33 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Sale | 22,544 | $54.01 | $1.2M | 0(D) | View → |
| Apr 28, 2026 | Apr 30 10:33 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Sale | 483,654 | $51.86 | $25.1M | 0(D) | View → |
| Apr 28, 2026 | Apr 29 8:46 PM | Barry D QuartDirector | Sale | 13,099 | $50.10 | $656.3K | 12,546(D) | View → |
| Apr 28, 2026 | Apr 28 8:49 PM | Patel Sanj K | Proposed Sale | 344,591 | $51.60 | $17.8M | — | View → |
| Apr 9, 2026 | Apr 13 8:35 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Sale | 6,625 | $46.69 | $309.3K | 27,418(D) | View → |
| Apr 9, 2026 | Apr 13 8:34 PM | Ross MoatCHIEF OPERATING OFFICER | Sale | 1,703 | $46.69 | $79.5K | 12,029(D) | View → |
| Apr 9, 2026 | Apr 9 8:03 PM | Moat Ross | Proposed Sale | 1,703 | $46.69 | $79.5K | — | View → |
| Apr 9, 2026 | Apr 9 8:02 PM | Megna Michael R | Proposed Sale | 6,625 | $46.69 | $309.3K | — | View → |
| Apr 6, 2026 | Apr 8 8:43 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Sale | 7,278 | $50.01 | $364.0K | 0(D) | View → |
| Apr 6, 2026 | Apr 8 8:39 PM | Ross MoatCHIEF OPERATING OFFICER | Sale | 2,367 | $48.58 | $115.0K | 12,029(D) | View → |
| Apr 6, 2026 | Apr 8 8:34 PM | Barry D QuartDirector | Sale | 6,901 | $50.00 | $345.1K | 12,546(D) | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | Apr 8 8:39 PM | Ross MoatCHIEF OPERATING OFFICER | Option Exercise | 2,477 | — | 0(D) | View → |
| Apr 7, 2026 | Apr 8 8:38 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Option Exercise | 3,932 | — | 0(D) | View → |
| Apr 6, 2026 | Apr 8 8:34 PM | Barry D QuartDirector | Option Exercise | 6,901 | $14.33 | 26,336(D) | View → |
| Apr 1, 2026 | Apr 3 8:41 PM | Eben TessariCHIEF STRATEGY OFFICER | Option Exercise | 5,975 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:41 PM | Eben TessariCHIEF STRATEGY OFFICER | Grant/Award | 58,100 | $48.13 | 16,600(D) | View → |
| Apr 1, 2026 | Apr 3 8:40 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Grant/Award | 54,550 | $48.13 | 15,600(D) | View → |
| Apr 1, 2026 | Apr 3 8:40 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 5,187 | — | 5,536(D) | View → |
| Apr 1, 2026 | Apr 3 8:39 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Option Exercise | 21,327 | — | 25,826(D) | View → |
| Apr 1, 2026 | Apr 3 8:39 PM | Sanj K PatelDirector, CHAIRMAN & CEO | Grant/Award | 210,300 | $48.13 | 60,100(D) | View → |
| Apr 1, 2026 | Apr 3 8:37 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Option Exercise | 5,831 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:37 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Grant/Award | 46,850 | $48.13 | 13,400(D) | View → |
| Apr 1, 2026 | Apr 3 8:35 PM | Ross MoatCHIEF OPERATING OFFICER | Grant/Award | 64,700 | $48.13 | 18,500(D) | View → |
| Apr 1, 2026 | Apr 3 8:35 PM | Ross MoatCHIEF OPERATING OFFICER | Option Exercise | 5,808 | — | 7,371(D) | View → |
| Apr 1, 2026 | Apr 3 8:34 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Grant/Award | 25,550 | $48.13 | 7,300(D) | View → |
| Apr 1, 2026 | Apr 3 8:34 PM | Michael R MegnaCHIEF ACCOUNTING OFFICER | Option Exercise | 7,564 | — | 7,931(D) | View → |
| Mar 9, 2026 | Mar 11 8:38 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 36,722 | $26.74 | 22,790(D) | View → |
| Mar 2, 2026 | Mar 4 9:40 PM | John F. PaoliniCHIEF MEDICAL OFFICER | Option Exercise | 40,000 | $10.36 | 58,424(D) | View → |
| Feb 12, 2026 | Feb 12 9:34 PM | Barry D QuartDirector | Option Exercise | 2,690 | $15.47 | 0(D) | View → |
| Feb 10, 2026 | Feb 12 9:34 PM | Barry D QuartDirector | Option Exercise | 110 | $15.47 | 2,690(D) | View → |
| Feb 9, 2026 | Feb 11 9:38 PM | Mark RagosaCHIEF FINANCIAL OFFICER | Option Exercise | 10,845 | $16.90 | 0(D) | View → |